RESEARCH TEAM
CEO & Co-Founder - Researcher
MA. Juan Manuel Mancilla-Tapia
Current director of OBI-K19. Canine services consultant with experience in epilepsy service dogs and COVID-19 canine detection training. Responsible for the COVID-19 canine detection biomedical research project with the National Council of Science and Technology (CONACYT).
CIO & Co-Founder - Researcher
Dr. Victoria Lozano-Esparza
Cofundadora, investigadora y consultora en biodetección canina y perros de servicio en personas con condiciones médicas. Miembro clave en la gestión de nuestro proyecto de investigación biomédica de detección canina de COVID-19 con el Consejo Nacional de Ciencia y Tecnología (CONACYT).
Laboratory Manager
Aracely Galaz Castillo
Laboratory manager. BSc. Chemistry from Universidad de Sonora (UNISON). Galaz has experience in clinical laboratory procedures, COVID-19 medical testing, and biological sample management with applications in canine bio-detection.
Collaborator & Science Advisor
Dr. William Schneider
PhD. Genetics from Michigan State University. BSc. Biology from the University of Minnesota/Duluth. He worked for 16 years for the US Department of Agriculture at the Foreign Disease/Weed Science Research Unit. 20 years of experience as a molecular biologist, studying virology, insect transmitted diseases and pathogen evolution. Over the course of his career Dr. Schneider has worked on numerous diagnostic tools for pathogens, including PCR, real-time PCR, deep sequencing and mass spectrometry. Dr Schneider is OBI K19’s advisor in the COVID-19 training aid technology. He also plays a role in the scientific validation of our COVID-19 bio-detection dogs.
Collaborator & Science Advisor
Dr. Victor Manuel Vidal Martinez
PhD. Biological Sciences (Parasite ecology) from the University of Exeter, Exeter, UK. BSc. Biology from Universidad Autonoma de Mexico (UNAM). Staff member in the Aquatic Pathology Laboratory of the Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV in Spanish) in Merida, Yucatan, Mexico. Dr. Vidal is our lead researcher and advisor for the COVID-19 volatile organic compounds (VOCs) characterization study.
Collaborator & Medical Advisor
MD. Isaac Chávez
Medical doctor with a specialty in anesthesiology, and practitioner for the Mexican Social Security Institute (Instituto Mexicano del Seguro Social, IMSS). Dr. Chavez is OBI-K19’s medical advisor regarding patients with COVID-19.